NCT02501876View on ClinicalTrials.gov

Type 2 Diabetes Mellitus as Catalyst for Alzheimer's Disease

CompletedOBSERVATIONAL
Enrollment

202

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

May 31, 2016

Conditions
Alzheimer´s DiseaseDiabetes Mellitus Type 2
Interventions
OTHER

There is a retrospectiv observational study. No intervention

There is a retrospectiv observational study. No intervention will be performed

Trial Locations (1)

08035

Vall d´Hebron University Hospital, Barcelona

All Listed Sponsors
lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER

NCT02501876 - Type 2 Diabetes Mellitus as Catalyst for Alzheimer's Disease | Biotech Hunter | Biotech Hunter